Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 October 2024 | Story André Damons | Photo Supplied
Dr Mutshidzi Mulondo
Dr Mutshidzi Mulondo, academic in the Division of Public Health within the Faculty of Health Sciences at UFS.

Dr Mutshidzi Mulondo, an academic in the Division of Public Health within the Faculty of Health Sciences, at the University of the Free State (UFS), has won a prestigious Global Health Award at the margins of the Global Health Summit in London, the UK.

Dr Mulondo, who is a Novartis Reimagining Healthcare Scholar and a Visiting Scholar at the Beaver College of Health Sciences at Appalachian State University, in the US, was a finalist in two categories: ‘Mental Health and Well-being’ and ‘Rising Star’. She won the Zenith Global Health Award under the category ‘Mental Health and Well-being’. The awards ceremony took place on 28 September and saw health professionals and academics gather in Europe for the auspicious occasion.

“This nomination and selection are an honour that bears testament to my dedication and commitment to SDG 3 (Good Health and Well-being). I hope this win serves as inspiration to young people, particularly to young women in academia and in the sciences,” says Dr Mulondo. The awards are an esteemed platform renowned for celebrating global recognition and excellence, fostering collaboration and innovation in the healthcare sector. They further serve as recognition for contributions made through education, research and/or technology and innovation.

Eco-anxiety

Dr Mulondo, who was invited to attend the summit for the first time, joined a panel of speakers on the session theme ‘mental health and climate change’ where she shared insights on eco-anxiety – the intersection of climate change and mental health which was coined by Albrecht as the chronic fear of environmental change.

Research by the McKinsey Health Institute, says Dr Mulondo, a fellow of the UFS Emerging Scholar Accelerator Programme (ESAP) and member of the UNESCO AG for Women in Science, indicates that more than 75% of young people are pessimistic about the future due to climate change. Most young people in the activism frontlines experience activist burn-out from consistent campaigning, while others experience eco-gaslighting from those who feel climate change is a non-issue. These negative emotions are further exacerbated by young people’s exposure to social media of constant images and conversations about environmental degradation due to climate change.

Pact for the future

Dr Mulondo flew to London from New York after participating in the 79th United Nations General Assembly’s Summit of the Future and Science Summit, as well as the New York Climate Week. She further provided insights into the adoption of the Pact for the Future which was adopted during the Summit of the Future. “With only 17% of the Sustainable Development Goals (SDGs) targets on track to be achieved by 2030, 18% stagnant and 17% regressed to pre-2015 when the goals were first adopted (SDG Report 2024), Mental Health still remains among 10 global health issues to track according to the World Health Organisation (WHO),” says Dr Mulondo.

“The Summit of the Future, which is regarded as a once-in-a-generation high-level event,” she continues, “was aimed at establishing a new global consensus to safeguard the present and future generations. Current challenges such as health pandemics, political unrest, and climatic changes were factored into discussions to keep apace with the changing world in the adoption of the Pact for the Future”.

Recommendations and mitigation efforts should focus on encouraging those experiencing eco-anxiety to focus on joining collective action efforts (i.e. campaigns to clean ocean and beach environments (etc,) so that they feel they are doing something towards saving the planet. “This will help alleviate the feelings of ‘hopelessness’ which some experience from not knowing what to do about the environmental degradation. Furthermore, intergenerational collaboration is necessary for young people to voice their concerns and innovative ideas on the issue, while the older generation listens and further shares their lived wisdom. Ultimately, collective support (Ubuntu) is what is needed as part of the mitigation efforts,” concludes Dr Mulondo.

News Archive

Inaugural lecture: Prof Robert Bragg, Dept. of Microbial, Biochemical and Food Biotechnology
2006-05-17



Attending the inaugural lecture were in front from the left Prof Robert Bragg (lecturer at the Department of Microbial, Biochemical and Food Biotechnology) and Frederick Fourie (Rector and Vice-Chancellor).  At the back from the left were Prof James du Preez (Departmental Chairperson:  Department of Microbial, Biochemical and Food Biotechnology) and Prof Herman van Schalkwyk (Dean: Faculty of Natural and Agricultural Sciences). Photo: Stephen Collett
 

A summary of an inaugural lecture delivered by Prof Robert Bragg at the University of the Free State:

CONTROL OF INFECTIOUS AVIAN DISEASES – LESSONS FOR MAN?

Prof Robert R Bragg
Department of Microbial, Biochemical and Food Biotechnology
University of the Free State

“Many of the lessons learnt in disease control in poultry will have application on human medicine,” said Prof Robert Bragg, lecturer at the University of the Free State’s (UFS) Department of Microbial, Biochemical and Food Biotechnology during his inaugural lecture.

Prof Bragg said the development of vaccines remains the main stay of disease control in humans as well as in avian species.  Disease control can not rely on vaccination alone and other disease-control options must be examined.  

“With the increasing problems of antibiotic resistance, the use of disinfection and bio security are becoming more important,” he said.

“Avian influenza (AI) is an example of a disease which can spread from birds to humans.  Hopefully this virus will not develop human to human transmission,” said Prof Bragg.

According to Prof Bragg, South Africa is not on the migration route of water birds, which are the main transmitters of AI.  “This makes South Africa one of the countries less likely to get the disease,” he said.

If the AI virus does develop human to human transmission, it could make the 1918 flu pandemic pale into insignificance.  During the 1918 flu pandemic, the virus had a mortality rate of only 3%, yet more than 50 million people died.

Although the AI virus has not developed human-to-human transmission, all human cases have been related to direct contact with infected birds. The mortality rate in humans who have contracted this virus is 67%.

“Apart from the obvious fears for the human population, this virus is a very serious poultry pathogen and can cause 100% mortality in poultry populations.  Poultry meat and egg production is the staple protein source in most countries around the world. The virus is currently devastating the poultry industry world-wide,” said Prof Bragg.

Prof Bragg’s research activities on avian diseases started off with the investigation of diseases in poultry.  “The average life cycle of a broiler chicken is 42 days.  After this short time, they are slaughtered.  As a result of the short generation time in poultry, one can observe changes in microbial populations as a result of the use of vaccines, antibiotics and disinfectants,” said Prof Bragg.   

“Much of my research effort has been directed towards the control of infectious coryza in layers, which is caused by the bacterium Avibacterium paragallinarum.  This disease is a type of sinusitis in the layer chickens and can cause a drop in egg product of up to 40%,” said Prof Bragg.

The vaccines used around the world in an attempt to control this disease are all inactivated vaccines. One of the most important points is the selection of the correct strains of the bacterium to use in the vaccine.

Prof Bragg established that in South Africa, there are four different serovars of the bacterium and one of these, the serovar C-3 strain, was believed to be unique to Southern Africa. He also recently discovered this serovar for the first time in Israel, thus indicating that this serovar might have a wider distribution than originally believed.

Vaccines used in this country did not contain this serovar.  Prof Bragg established that the long term use of vaccines not containing the local South African strain resulted in a shift in the population distribution of the pathogen.

Prof Bragg’s research activities also include disease control in parrots and pigeons.   “One of the main research projects in my group is on the disease in parrots caused by the circovirus Beak and Feather Disease virus. This virus causes serious problems in the parrot breeding industry in this country. This virus is also threatening the highly endangered and endemic Cape Parrot,” said Prof Bragg.

Prof Bragg’s research group is currently working on the development of a DNA vaccine which will assist in the control of the disease, not only in the parrot breeding industry, but also to help the highly endangered Cape Parrot in its battle for survival.

“Not all of our research efforts are directed towards infectious coryza or the Beak and Feather Disease virus.  One of my Masters students is currently investigating the cell receptors involved in the binding of Newcastle Disease virus to cancerous cells and normal cells of humans. This work will also eventually lead to a possible treatment of cancer in humans and will assist with the development of a recombinant vaccine for Newcastle disease virus,” said Prof Bragg.

We are also currently investigating an “unknown” virus which causes disease problems in poultry in the Western Cape,” said Prof Bragg.
 
“Although disinfection has been extensively used in the poultry industry, it has only been done at the pre-placement stage. In other words, disinfectants are used before the birds are placed into the house. Once the birds are placed, all use of disinfectants stops,” said Prof Bragg.

“Disinfection and bio security can be seen as the ‘Cinderella’ of disease control in poultry.  This is also true for human medicine. One just has to look at the high numbers of people who die from hospital-acquired infections to realise that disinfection is not a concept which is really clear in human health care,” said Prof Bragg.

Much research has been done in the control of diseases through vaccination and through the use of antibiotics. “These pillars of disease control are, however, starting to crumble and more effort is needed on disinfection and bio security,” said Prof Bragg.

Prof Bragg has been working in close co-operation with a chemical manufacturing company in Stellenbosch to develop a unique disinfectant which his highly effective yet not toxic to the birds.

As a result of this unique product, he has developed the continual disinfection program for use in poultry. In this program the disinfectant is used throughout the production cycle of the birds. It is also used to ensure that there is excellent pre-placement disinfection.

“The program is extensively used for the control of infectious diseases in the parrot-breeding industry in South Africa and the product has been registered in 15 countries around the world with registration in the USA in the final process,” said Prof Bragg.

“Although the problem of plasmid mediated resistance to disinfectants is starting to rear its ugly head, this has allowed for the opening of a new research field which my group will hopefully exploit in the near future,” he said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept